Close
ACHEMA MIDDLE EAST 2026

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Cerecor Inc., a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced...

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Johnson & Johnson announced that the U.S. FDA has issued EUA for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson...

Full service: the expertise and efficiency of a one-stop shop

When it comes to the manufacturing of drugs, particularly highly sensitive biologics, a high-level of expertise is required. Typically, small and medium-sized pharma and biotech...

UCB and Microsoft expand drug development partnership

UCB and Microsoft have entered into a new multi-year, strategic collaboration. The collaboration will merge Microsoft’s computational services, Cloud and artificial intelligence (AI) with...

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

Exscientia, a leading AI Drug Discovery company, has announced its collaboration with the Alzheimer’s Research UK University of Oxford Drug Discovery Institute (ARUK-ODDI) to...

PDA to Collaborate with Deloitte and U.S. FDA to Improve the Quality of Compounded Drugs

The Parenteral Drug Association (PDA) announced it has signed an agreement to collaborate with Deloitte Consulting, LLP and the U.S. FDA’s Compounding Quality Center...

AstraZeneca and IDT Biologika sign LOI to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

EMA approval, millions of AstraZeneca vaccines began shipping on 5 February as part of the initial 17m doses that are due to be delivered...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...